Acelyrin, Inc.
SLRN
$4.39
-$0.24-5.18%
| Weiss Ratings | SLRN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | SLRN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | SLRN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -- | |||
| Price History | SLRN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -10.04% | |||
| 30-Day Total Return | -27.44% | |||
| 60-Day Total Return | -40.76% | |||
| 90-Day Total Return | -39.78% | |||
| Year to Date Total Return | -44.71% | |||
| 1-Year Total Return | -80.66% | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -85.31% | |||
| 52-Week Low % Change | 6.04% | |||
| Price | SLRN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $29.88 | |||
| 52-Week Low Price | $4.14 | |||
| 52-Week Low Price (Date) | Apr 30, 2024 | |||
| 52-Week High Price (Date) | Aug 23, 2023 | |||
| Valuation | SLRN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 434.73M | |||
| Enterprise Value | -242.45M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -2.60 | |||
| Earnings Per Share Growth | -92.77% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | 0.67 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $4.39 | |||
| Enterprise Value/EBITDA (TTM) | 0.74 | |||
| Enterprise Value/EBIT | 0.74 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | SLRN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 97.91M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | SLRN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 805-730-0360 | |||
| Address | 4149 Liberty Canyon Road Agoura Hills, CA 91301 | |||
| Website | www.acelyrin.com | |||
| Country | United States | |||
| Year Founded | 2020 | |||
| Profitability | SLRN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | SLRN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -41.34% | |||
| Return on Equity | -- | |||
| Income Statement | SLRN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -329.25M | |||
| EBIT (TTM) | -329.41M | |||
| Net Income (TTM) | -240.16M | |||
| Net Income Avl. to Common (TTM) | -240.16M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 80.18% | |||
| EPS Diluted (TTM) | -2.60 | |||
| EPS Diluted Growth (Q YOY) | 95.85% | |||
| Balance Sheet | SLRN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 678.54M | |||
| Cash Per Share (Q) | $6.93 | |||
| Total Current Assets (Q) | 693.98M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 644.07M | |||
| Current Ratio (Q) | 13.274 | |||
| Book Value Per Share (Q) | $6.52 | |||
| Total Assets (Q) | 697.48M | |||
| Total Current Liabilities (Q) | 52.28M | |||
| Total Debt (Q) | 1.36M | |||
| Total Liabilities (Q) | 53.42M | |||
| Total Common Equity (Q) | 644.07M | |||
| Cash Flow | SLRN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -394.39M | |||
| Cash from Financing (TTM) | 571.37M | |||
| Net Change in Cash (TTM) | -24.69M | |||
| Levered Free Cash Flow (TTM) | -141.87M | |||
| Cash from Operations (TTM) | -201.68M | |||
